Filing Details
- Accession Number:
- 0001578259-14-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-15 17:24:46
- Reporting Period:
- 2014-07-11
- Filing Date:
- 2014-07-15
- Accepted Time:
- 2014-07-15 17:24:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
827809 | Qlt Inc | QLTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1360509 | Florian Schonharting | Ostergade 24A, 1 Dk-1100 Copenhagen K G7 | No | No | Yes | No | |
1451330 | K/S Equity Public Nb | Ostergade 24A, 1 Dk-1100 Copenhagen K G7 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Disposition | 2014-07-11 | 1,000,000 | $5.80 | 6,447,626 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owner.
- Florian Schonharting is a direct investor in a limited partner in the Fund and a director of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Mr. Schonharting disclaims beneficial ownership in the securities, except to the extent of his pecuniary interest therein.